hepcinat 400mg medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking hepcinat 400mg medicine. hepcinat 400mg medicine is not recommended for use in breastfeeding women unless absolutely necessary. All hepcinat 400mg risks and benefits should be discussed with the doctor before taking this medicine.
hepcinat 400mg medicine should be used with extreme caution in combination with amiodarone due to the increased risk of life-threatening cardiac complications including fatal cardiac arrest. hepcinat 400mg risk is especially higher in the first 48 hours of starting treatment with both these medicines. Coadministration of these medicines should be done only under close medical supervision with provisions to continuously monitor all vital signs of the patient. Replacement with a suitable alternative may be done based on the clinical condition of the patient.